# XBIO (Xenetic Biosciences, Inc.) - SEC EDGAR Financial Statements

> Xenetic Biosciences, Inc. reported $2.96M in revenue and a net loss of $3.66M for the trailing twelve months ended September 30, 2026 (down 29.4% year over year), with a -129.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/XBIO
- Markdown: https://convexityos.com/fundamentals/XBIO.md
- SEC CIK: 0001534525
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001534525&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $2.96M | -29.4% YoY |
| Operating Income | TTM | -$3.84M | -129.6% margin |
| Net Income | TTM | -$3.66M | -123.7% net margin |
| Diluted EPS | TTM | -$1.56 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | -- | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.98M | $2.50M | $2.54M | $1.71M | $1.16M | $437K | $17K | $0 | $7.58M | $3.00M |
| Research & Development | $3.07M | $3.29M | $3.49M | $4.77M | $3.16M | $1.73M | $4.89M | $2.88M | $4.06M | $43.74M |
| Total Operating Expenses | $5.81M | $6.70M | $7.06M | $8.42M | $6.91M | $14.37M | $12.90M | $7.28M | -- | -- |
| **Operating Income** | -$2.83M | -$4.20M | -$4.52M | -$6.72M | -$5.75M | -$13.94M | -$12.89M | -$7.28M | -$3.57M | -$47.43M |
| **EBITDA** | -- | -- | -- | -$6.72M | -$5.75M | -$13.94M | -$12.88M | -$7.26M | -$3.54M | -$47.39M |
| Interest Income | -- | -- | -- | -- | -- | -- | -- | -- | $17K | $32 |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | $1.8K | $730K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | -$2.92M | $0 | $0 | $0 | $0 |
| **Net Income** | -$2.68M | -$3.96M | -$4.13M | -$6.55M | -$5.65M | -$10.89M | -$12.78M | -$7.30M | -$3.60M | -$54.21M |
| Basic EPS | -$1.58 | -$2.57 | -$2.71 | -$4.61 | -$5.50 | -$17.00 | -$63.30 | -$1,159.66 | -$49.22 | -$941.18 |
| **Diluted EPS** | -$1.58 | -$2.57 | -$2.71 | -$4.61 | -$5.50 | -$17.00 | -$63.30 | -$1,159.66 | -$49.22 | -$941.18 |
| Basic Shares Outstanding | 1.7M | 1.5M | 1.5M | 1.4M | 1.0M | 639.2K | 285.2K | 6.3K | 72.2K | 61.9K |
| Diluted Shares Outstanding | 1.7M | 1.5M | 1.5M | 1.4M | 1.0M | 639.2K | 285.2K | 6.3K | 72.2K | 61.9K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $725K | $661K | $807K | $766K | $1.03M | $590K | $593K | $649K |
| Research & Development | $521K | $552K | $661K | $773K | $756K | $657K | $879K | $1.04M |
| Total Operating Expenses | $2.46M | $1.63M | $1.31M | $1.39M | $1.57M | $1.31M | $1.54M | $1.75M |
| **Operating Income** | -$1.74M | -$972K | -$502K | -$623K | -$545K | -$724K | -$942K | -$1.10M |
| Interest Income | -- | $42K | $46K | -- | -- | $34K | $39K | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$1.70M | -$930K | -$456K | -$579K | -$510K | -$689K | -$903K | -$1.05M |
| Basic EPS | -$0.72 | -$0.41 | -$0.20 | -- | -$0.33 | -$0.45 | -$0.59 | -- |
| **Diluted EPS** | -$0.72 | -$0.41 | -$0.20 | -- | -$0.33 | -$0.45 | -$0.59 | -- |
| Basic Shares Outstanding | 2.3M | 2.3M | 2.3M | -- | 1.5M | 1.5M | 1.5M | -- |
| Diluted Shares Outstanding | 2.3M | 2.3M | 2.3M | -- | 1.5M | 1.5M | 1.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $7.88M | $6.17M | $8.98M | $13.10M | $18.24M | $11.53M | $10.37M | $572K | $5.53M | $4.05M |
| **Cash & Short-Term Investments** | $7.88M | $6.17M | $8.98M | $13.10M | $18.24M | $11.53M | $10.37M | $572K | $5.53M | $4.05M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $3.00M |
| **Total Current Assets** | $8.05M | $6.59M | $9.59M | $13.65M | $18.72M | $12.37M | $11.09M | $1.19M | $5.88M | $8.34M |
| Property, Plant & Equipment, Net | -- | -- | -- | $0 | $0 | $0 | $757 | $5.0K | $28K | $42K |
| Goodwill | -- | -- | -- | -- | -- | $0 | $9.24M | $3.28M | $3.28M | $3.28M |
| Other Non-Current Assets | $314K | $314K | $1.02M | $1.07M | $1.09M | $810K | $1.21M | $706K | $725K | $66K |
| **Total Non-Current Assets** | $314K | $314K | $1.02M | $1.07M | $1.09M | $810K | $10.46M | $13.24M | $13.28M | $12.64M |
| **Total Assets** | $8.36M | $6.90M | $10.61M | $14.72M | $19.82M | $13.18M | $21.55M | $14.43M | $19.16M | $20.97M |
| Accounts Payable | $258K | $284K | $241K | $287K | $362K | $327K | $931K | $934K | $787K | $1.01M |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $666K | $21K | $20K |
| **Total Current Liabilities** | $968K | $894K | $810K | $1.07M | $1.42M | $937K | $1.42M | $1.60M | $1.94M | $1.87M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $0 | $0 | $20K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $27K | $2.92M | $2.92M | $2.92M | $2.94M |
| **Total Liabilities** | $968K | $894K | $810K | $1.07M | $1.42M | $964K | $4.33M | $4.52M | $4.86M | $4.80M |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | $63K | $20K | -- | -- | -- |
| Common Stock | $2.3K | $1.5K | $1.5K | $1.5K | $13K | $8.8K | $6.1K | $811 | $9.0K | $8.7K |
| Retained Earnings | -$199.9M | -$197.2M | -$193.2M | -$189.1M | -$182.5M | -$176.9M | -$166.0M | -$153.2M | -$145.9M | -$142.3M |
| Accumulated Other Comp. Income | $254K | $254K | $254K | $254K | $254K | $254K | $254K | $254K | $254K | $254K |
| **Total Stockholders' Equity** | $7.40M | $6.01M | $9.80M | $13.65M | $18.39M | $12.22M | $17.21M | $9.91M | $14.30M | $16.17M |
| Total Equity | $7.40M | $6.01M | $9.80M | $13.65M | $18.39M | $12.22M | $17.21M | $9.91M | $14.30M | $16.17M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | $7.35M | $7.88M | -- | -- | $5.16M | $6.17M |
| **Cash & Short-Term Investments** | -- | -- | $7.35M | $7.88M | -- | -- | $5.16M | $6.17M |
| **Total Current Assets** | $6.00M | $6.65M | $7.60M | $8.05M | $5.07M | $5.35M | $5.48M | $6.59M |
| Other Non-Current Assets | $314K | $314K | $314K | $314K | $0 | $0 | $314K | $314K |
| **Total Non-Current Assets** | $314K | $314K | $314K | $314K | $0 | $0 | $314K | $314K |
| **Total Assets** | $6.32M | $6.97M | $7.91M | $8.36M | $5.07M | $5.35M | $5.79M | $6.90M |
| Accounts Payable | $1.41M | $323K | $559K | $258K | $578K | $347K | $240K | $284K |
| **Total Current Liabilities** | $1.90M | $895K | $958K | $968K | $1.11M | $903K | $668K | $894K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $1.90M | $895K | $958K | $968K | $1.11M | $903K | $668K | $894K |
| Common Stock | $2.3K | $2.3K | $2.3K | $2.3K | $1.5K | $1.5K | $1.5K | $1.5K |
| Retained Earnings | -$203.0M | -$201.3M | -$200.3M | -$199.9M | -$199.3M | -$198.8M | -$198.1M | -$197.2M |
| Accumulated Other Comp. Income | $254K | $254K | $254K | $254K | $254K | $254K | $254K | $254K |
| **Total Stockholders' Equity** | $4.41M | $6.07M | $6.95M | $7.40M | $3.96M | $4.45M | $5.12M | $6.01M |
| Total Equity | $4.41M | $6.07M | $6.95M | $7.40M | $3.96M | $4.45M | $5.12M | $6.01M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.68M | -$3.96M | -$4.13M | -$6.55M | -$5.65M | -$13.81M | -$12.78M | -$7.30M | -$3.60M | -$54.21M |
| Depreciation & Amortization | -- | -- | -- | $0 | $0 | $1.0K | $4.2K | $16K | $24K | $36K |
| Stock-Based Compensation | $65K | $172K | $283K | $511K | $410K | $469K | $806K | $1.36M | $1.78M | $1.92M |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | $0 | $3.00M | -$3.00M |
| **Operating Cash Flow** | -$2.29M | -$2.82M | -$4.11M | -$4.65M | -$4.74M | -$4.27M | -$6.40M | -$6.46M | $1.49M | -$8.79M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | $0 | -$9.3K | -$17K |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$6.46M | $1.48M | -$8.80M |
| **Investing Cash Flow** | -- | -- | $0 | -$500K | $0 | $0 | $2.0K | $22K | -$9.3K | -$17K |
| Common Stock Issued | $4.00M | $0 | -- | $0 | $11.45M | $5.43M | $0 | $0 | -- | -- |
| **Financing Cash Flow** | $4.00M | $0 | -- | $0 | $11.45M | $5.43M | $16.13M | $1.48M | $0 | $12.72M |
| **Net Change in Cash** | $1.72M | -$2.82M | -$4.11M | -$5.15M | $6.72M | $1.16M | $9.73M | -$4.96M | $1.48M | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.70M | -$930K | -$456K | -$579K | -$510K | -$689K | -$903K | -$1.05M |
| Stock-Based Compensation | $36K | $52K | $11K | $14K | $16K | $16K | $19K | $25K |
| **Operating Cash Flow** | -$662K | -$875K | -$536K | -$243K | -$658K | -$384K | -$1.00M | -$674K |
| **Net Change in Cash** | -$662K | -$875K | -$536K | $3.76M | -$658K | -$384K | -$1.00M | -$674K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -95.2% | -168.2% | -177.8% | -393.6% | -495.1% | -3189.8% | -75511.7% | -- | -47.1% | -1581.0% |
| **Net Profit Margin** | -90.1% | -158.4% | -162.8% | -383.9% | -486.4% | -2493.1% | -74856.6% | -- | -47.4% | -1806.9% |
| Return on Equity (ROE) | -36.2% | -65.9% | -42.2% | -48.0% | -30.7% | -89.2% | -74.2% | -73.6% | -25.1% | -335.2% |
| Return on Assets (ROA) | -32.1% | -57.4% | -39.0% | -44.5% | -28.5% | -82.7% | -59.3% | -50.6% | -18.8% | -258.4% |
| Current Ratio | 8.32x | 7.37x | 11.84x | 12.72x | 13.18x | 13.20x | 7.84x | 0.75x | 3.03x | 4.47x |
| Quick Ratio | 8.14x | 6.89x | 11.10x | 12.20x | 12.84x | 12.30x | 7.33x | 0.36x | 2.85x | 3.78x |
| Debt to Equity | -- | -- | -- | -- | -- | 0.01x | 0.00x | -- | -- | -- |
| **Revenue Growth (YoY)** | +19.0% | -1.6% | +48.8% | +47.1% | +165.6% | +2460.3% | -- | -100.0% | +152.8% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -532.6% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -535.3% | -- | -- |
| 5Y Revenue / Share Growth | +155.9% | +2611.3% | -- | -98.9% | -97.7% | -- | -- | -100.0% | +35623.0% | -- |
| 10Y Revenue / Share Growth | -- | -- | +65.9% | +308.0% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -129.6% | -81.0% | -75.1% | -95.2% | -115.8% | -133.5% | -150.2% | -168.2% |
| **Net Profit Margin** | -123.7% | -75.9% | -70.0% | -90.1% | -110.4% | -126.0% | -142.0% | -158.4% |
| Return on Equity (ROE) | -82.9% | -40.8% | -32.1% | -36.2% | -79.8% | -69.3% | -71.6% | -65.9% |
| Return on Assets (ROA) | -57.9% | -35.5% | -28.2% | -32.1% | -62.3% | -57.6% | -63.3% | -57.4% |
| Current Ratio | 3.15x | 7.43x | 7.93x | 8.32x | 4.56x | 5.93x | 8.20x | 7.37x |
| Quick Ratio | -- | -- | 7.67x | 8.14x | -- | -- | 7.73x | 6.89x |
| **Revenue Growth (YoY)** | -29.4% | +12.0% | +36.0% | +18.1% | +67.2% | -18.8% | +16.1% | -3.4% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
